Company / Gross Margin
Perspective Therapeutics, Inc. Gross Margin History
FY2013-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Margin
-
FY2022
5-year range
0.0% / 127.8%
FY2018-FY2022
Trend
-100.0%
vs FY2021
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from 79.6% to 0.0% over the past 2 years.
Gross Margin over time
Growth rates
- 3-Year Change
- -53.6pp
- 5-Year Change
- -3.6pp
- 10-Year Change
- -
Key checks
Key Insights
- In FY2022, gross margin decreased 100.0% year-over-year.
- Peak gross margin was recorded in FY2021.
- Lowest gross margin in the period was in FY2016.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 5.43 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2022 | 0.0% | -100.0% |
| FY2021 | 127.8% | +60.6% |
| FY2020 | 79.6% | +48.3% |
| FY2019 | 53.6% | +1887.0% |
| FY2018 | 2.7% | -25.6% |
| FY2017 | 3.6% | +177.9% |
| FY2016 | -4.7% | -240.4% |
| FY2015 | 3.3% | +0.0% |
| FY2014 | 3.3% | -76.1% |
| FY2013 | 13.9% | - |
As of FY2022 · SEC 10-K · Updated Jun 24, 2026